Metraipolis › archive › dc_0e994ca01842
Ultrasound-triggered doxorubicin targeted delivery for liver cancer treatment: Reduced toxicity and improved efficacy — Europe PMC PMID:41875121
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41875121
- DOI
- 10.1371/journal.pone.0345161
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T23:54:48.943Z
- SHA-256 of the archived text
2ecf6cd7653c4f8e4b3a2eeb000f84af876ce541c41263bb5f552dc16befd879- Stable URL of this page
https://metraipolis.com/documento/dc_0e994ca01842
How to cite
Ultrasound-triggered doxorubicin targeted delivery for liver cancer treatment: Reduced toxicity and improved efficacy — Europe PMC PMID:41875121 — Europe PMC (en), https://europepmc.org/article/MED/41875121 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e994ca01842 (Metraipolis archive dc_0e994ca01842, sha256 2ecf6cd7653c4f8e4b3a2eeb000f84af876ce541c41263bb5f552dc16befd879)
BibTeX
@misc{dc0e994ca01842,
title = {Ultrasound-triggered doxorubicin targeted delivery for liver cancer treatment: Reduced toxicity and improved efficacy — Europe PMC PMID:41875121},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41875121},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e994ca01842; sha256 2ecf6cd7653c4f8e4b3a2eeb000f84af876ce541c41263bb5f552dc16befd879},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41875121. Agents can read the archived copy with the MCP tool read_document.